Browse the latest news and insights from ActiMedi in one place.
ActiMedi (CEO Kim Jin-goo), an AI platform company specializing in sports medicine-based musculoskeletal rehabilitation, announced the signing of a Memorandum of Understanding (MOU) with Medipost (CEO Oh Won-il) — the company behind the world's first commercialized allogeneic umbilical cord blood-derived mesenchymal stem cell therapy, CARTISTEM® — on April 24, 2026, for joint entry into global markets.
ActiMedi Center, a rehabilitation solution for musculoskeletal patients, has been officially adopted at Newmin Hospital and is now in clinical use.
The MOU was signed with the core objective of building a patient-centered digital healthcare ecosystem that integrates the full cycle of "treatment–rehabilitation–prognosis management," combining the global competitiveness of Medipost's allogeneic umbilical cord blood-derived mesenchymal stem cell therapy CARTISTEM®, ActiMedi's AI/digital solution capabilities, and the clinical expertise of its advisory group.
Menus and content have been translated into English to support global partners and customers.
From Surgery to Daily Life: Digital Transformation of Knee Care. Host: Korean Arthroscopy Society | Organizer: Myongji Hospital, Exercise Is Medicine. [Symposium presentation topics] - The AI counseling service that never lies: ActiMedi TokTok - Functional recovery that extends into daily life: ActiMedi atHome - Measure, prescribe, and track: ActiMedi Gear - A new paradigm of clinical data: ActiMedi Ontology Hub - AI-driven paradigm shift in prevention, treatment, and rehabilitation
Barosun Hospital, a joint-specialized hospital in Dobong-gu, has opened a Sports Medicine Center equipped with advanced diagnostic equipment. The center precisely analyzes patients' physical performance and functional capacity using scientific tools such as dynamic EMG and dynamic plantar pressure testing, and provides customized recovery services based on objective numerical data. It operates a one-stop care system covering the general public, post-surgical patients, and professional athletes alike, led by Director Choi Jung-yoon, a specialist in knee arthroplasty and sports injuries.
Awarded the investment-grade technology rating of TI-3, recognizing strong technological capability and excellent future growth potential based on favorable market conditions (Evaluator: NICE Information Service Co., Ltd.).
Digital medical device Confirmatory Trial protocol approved by the Ministry of Food and Drug Safety (Dec 24, 2025 / No. 20).
ActiMedi Center, a rehabilitation solution for musculoskeletal patients, has been officially adopted at Seoul Jump Orthopedic Clinic and is now in clinical use.
ActiMedi Center, a rehabilitation solution for musculoskeletal patients, has been officially adopted at BAROSUN Hospital and is now in clinical use.
The AI registry data entry form has been standardized and upgraded to 2.0, and the first commercial version has been deployed at Myongji Hospital.
The launch of the ActiMedi TokTok KakaoTalk channel marks the start of a conversational service delivered through KakaoTalk.
"The surgery went well. Now you have to exercise diligently." This is the message orthopedic surgery patients hear most often from their doctors. But patients are left at a loss, unable to get clear answers to "What exercises, how, and how much?" After a few costly manual therapy sessions, that is usually the end of it. Most patients spend the critical "golden time" after surgery without proper rehabilitation, suffering through slow recovery and ongoing pain. Professor Kim Jin-goo (Medical Director, Department of Orthopedic Surgery, Hanyang University Myongji Hospital), a leading authority in knee sports medicine in Korea, has encountered countless such patients over the past 30 years. Knowing better than anyone that a patient's prognosis is determined not by the surgery itself but by consistent post-operative management and exercise, his frustration ran all the deeper.
Myongji Medical Foundation / MJH IRB 2025-09-019(AM-KOA-2025)
ActiMedi Center, a rehabilitation solution for musculoskeletal patients, has been officially adopted at Kwangdong Hospital and is now in clinical use
Version 1.0, supporting data entry and management, has been completed.
Completed a follow-on investment of KRW 2.55 billion from YP Alliance Co., Ltd. and Withwin Investment Co., Ltd.
The 4th Medical Revolution and the Evolving Virtual Sports Medical Center Host: Korean Arthroscopy Society | Organizer: Myongji Hospital, Exercise Is Medicine [Symposium presentation topics] - Knee osteoarthritis and strategies for strengthening surrounding muscles - Applications of artificial intelligence in arthritis treatment - Current status of Digital Therapeutics development for arthritis - Virtual Sports Medical Center
Following the corporate name change registration from "Metrax" to "ActiMedi" (Feb. 2025), company-wide rebranding has been completed.
ActiMedi Center, a rehabilitation solution for musculoskeletal patients, has joined forces with Myongji Hospital Sports Medicine Center
Signed an MOU with Gilon Co., Ltd. (CEO Kim Nam-sun) for the joint development of a knee osteoarthritis digital therapeutic (DTx) and a post-knee-surgery rehabilitation app.
Registered as a venture company under the Innovative Growth category.
Completed KRW 2.55 billion in investment from YP Alliance Co., Ltd. and Withwin Investment Co., Ltd.
The company was established under the name "Metrax."